Medline MDLN
NASDAQ MDLN
$34.75 +0.06 (+0.17%)
As of: Sep 9, 2026 · 10:38 AM EDT

Medline (MDLN) EV to CFO (2026)

Medline's (MDLN) quarterly EV to CFO came in at 78.22 in Q2 2026, down 46.45% quarter-over-quarter from 146.09 in Q1 2026.

Analysis

Medline (MDLN) EV to CFO (2026) Analysis & Trends

Medline (MDLN) has reported EV to CFO for 1 consecutive years, with 78.22 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to CFO changed N/A year-over-year to 78.22 in Q2 2026; TTM through Jun 2026 was 27.88, a N/A change from a year earlier, with the FY2025 full-year figure at 35.44, changed N/A from the prior year.
  • EV to CFO was 78.22 for Q2 2026 at Medline, down from 146.09 in the prior quarter.
  • Over five years, EV to CFO peaked at 146.09 in Q1 2026 and troughed at 78.22 in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Becton Dickinson 49.51 Bn 48.65 Bn 2.32 Bn
2 Medline 29.85 Bn 27.17 Bn 2.22 Bn
3 West Pharmaceutical Services 24.00 Bn 23.56 Bn 329.20 Mn
4 Baxter International 12.94 Bn 10.79 Bn 1.03 Bn
5 Stevanato Group S.p.A 5.54 Bn 5.43 Bn 100.91 Mn
6 Acme United 234.28 Mn 229.24 Mn 26.69 Mn
7 Rockwell Medical 31.04 Mn 6.24 Mn 3.24 Mn
8 Retractable Technologies 20.96 Mn -18.91 Mn 190,852.00
9 United Health Products 9.59 Mn 9.56 Mn -
10 Cuprina Holdings (Cayman) 8.14 Mn 5.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 78.22
Mar 28, 2026 146.09